Who are DFD-29's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Silver diamine fluoride, azelaic acid 15% gel, Benzoyl peroxide 5% gel, Topical Antimicrobial/Antifungal Medications, Silver Diamine Fluoride (SDF), Neutrogena Rapid Clear®.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dfd-29.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

DFD-29 — Competitive Intelligence Brief

DFD-29 (DFD-29) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical antimicrobial. Area: Dermatology.

phase 3 Topical antimicrobial Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

DFD-29 (DFD-29) — Journey Medical Corporation. DFD-29 is a topical antimicrobial agent designed to treat bacterial skin infections by disrupting bacterial cell function.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
DFD-29 TARGET	DFD-29	Journey Medical Corporation	phase 3	Topical antimicrobial
Silver diamine fluoride	Silver diamine fluoride	Postgraduate Institute of Dental Sciences Rohtak	marketed	Topical antimicrobial and remineralizing agent
azelaic acid 15% gel	azelaic acid 15% gel	Galderma R&D	marketed	Topical antimicrobial and anti-inflammatory agent
Benzoyl peroxide 5% gel	Benzoyl peroxide 5% gel	University of Southern California	marketed	Topical antimicrobial and keratolytic agent
Topical Antimicrobial/Antifungal Medications	Topical Antimicrobial/Antifungal Medications	Mylan Inc.	marketed	Topical antimicrobial/antifungal agents (multiple classes)
Silver Diamine Fluoride (SDF)	Silver Diamine Fluoride (SDF)	Umm Al-Qura University	marketed	Topical antimicrobial and remineralizing agent
Neutrogena Rapid Clear®	Neutrogena Rapid Clear®	GlaxoSmithKline	marketed	Topical antimicrobial/keratolytic agent	Cutibacterium acnes (bacterial cell membranes and proteins)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical antimicrobial class)

Journey Medical Corporation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). DFD-29 — Competitive Intelligence Brief. https://druglandscape.com/ci/dfd-29. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab